Ask for high quality link by putting your email below

Please, double check your email!

BIOMIMESYS® range are hyaluronan based hydroscaffold developed to overcome the 2D flat culture limitations by recreating an in vivo-like physiology within the in vitro environment.
BIOMIMESYS®Liver scaffold is made of RGDS and galactosamine-grafted Hyaluronic acid, Adipic acid dihydrazide crosslinker and extracellular matrix (ECM) proteins (collagen type I and collagen type IV) to mimic liver-ECM composition.



Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

1 Comment

Innovation for hepatotoxicity in vitro research models | HCS Pharma · July 16, 2019 at 1:49 pm

[…] better mimic the cell microenvironment, we have developed in vitro tests in different models and thanks to our technology for 3D cell culture BIOMIMESYS® Liver hydroscaffold we can model the […]

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: